Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes.
Giuseppe FerreraSalvatore D'AlessandroFrancesco CucciaVincenzo SerrettaGiovanna TrapaniGianfranco SavocaGianluca MortellaroAntonio Lo CastoPublished in: Journal of cancer research and clinical oncology (2021)
Our experience supports the use of moderate hypofractionation for prostate bed radiotherapy, with minimal toxicity and promising results in terms of clinical outcomes.